EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act

Robin Feldman iD

PLOS Medicine · 2024

DOI: 10.1371/journal.pmed.1004381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Medicine, 2024. Verfasst von Robin Feldman. Beteiligte Einrichtung: University of California Law, San Francisco, California, United States of America. Hauptthemen laut MEDLINE: Intellectual Property, Biosimilar Pharmaceuticals. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this Policy Forum piece, Robin Feldman discusses how current legislation contributes to informational deficits around drug patents for biologic drugs in the United States.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual PropertyBiosimilar PharmaceuticalsUnited StatesHumansBiological ProductsPatents as TopicLegislation, DrugUnited States Food and Drug Administration

Substanzen

Biosimilar PharmaceuticalsBiological Products

Autor:innen und Institutionen

  • University of California Law, San Francisco, California, United States of America.

ORCID-Profile: Robin Feldman

Zitieren

APA

Feldman, R. (2024). Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004381

Vancouver

Feldman R. Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act. PLOS Medicine. 2024. doi:10.1371/journal.pmed.1004381

BibTeX
@article{Feldman2024,
  author = {Feldman, Robin},
  title = {Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act},
  journal = {PLOS Medicine},
  year = {2024},
  doi = {10.1371/journal.pmed.1004381}
}
Kostenlos starten →